The study of predictive factors for the effect of Salmeterol/Fluticasone combination(SFC) on the patients with obstructive pulmonary dysfunction.
Not Applicable
Recruiting
- Conditions
- obstructive pulmonary dysfunction
- Registration Number
- JPRN-UMIN000010276
- Lead Sponsor
- Kagoshima university pulmonary medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1) medication of corticosteroid in 4wks 2) medication of anticholinergic drug in 4wks 3) medication of long acting beta agonist in 4 wks 4) inhalation of short acting beta agonist in 6hrs 5) patients who has heart failure, severe arrhythmia. 6) medication of beta blocker 7) active infectious disease and tuberculous disease 8) pationts who had resected lung 9) psycosomatic patients 10) allergy for SFC 11) difficult to do spirometry 12) pregnancy 13) diagnosis for other pulmonary disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method